Video: Avoiding Mistakes in Posterior Uveitis Care
-
By
-
Diana V. Do, MD
-
Quan Dong Nguyen, MD
-
October 1, 2025
-
2 min
By
Diana V. Do, MD
Quan Dong Nguyen, MD
October 1, 2025
by Diana V. Do, MD, Quan Dong Nguyen, MD
October 1, 2025
The movement of immune cells through the retinal vasculature has long been inferred from laboratory models. Now, advances in imaging are allowing clinicians to observe these processes directly. At the 2026 meeting of the Association for Research in Vision and Ophthalmology (ARVO) in Denver, Richard B. Rosen, MD, ScD(hon), FACS, FASRS, FARVO, described early clinical work using adaptive optics scanning laser ophthalmoscopy (AOSLO) to visualize leukocyte trafficking in vivo.
May 1, 2026
A large cohort study suggests uveitis risk is lower in patients taking GLP-1 receptor agonists, compared to other antihyperglycemic drugs.
September 1, 2025
Vamikibart shows promise as a new treatment for uveitic macular edema, improving vision and safety compared to existing steroids. Source: Dr. Rahul Khurana.
January 1, 2026